Glycopyrrolate Injection
Product Images NDC 71872-7292

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 71872-7292). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7187272921.jpg (7187272921)

Label for Glycopyrrolate Injection, USP, 4 mg/20 mL (0.2 mg/mL) multiple dose vial. The label specifies intramuscular or intravenous use, storage at 20° to 25°C (68°–77°F), and includes warnings about benzyl alcohol and use in newborns. Manufactured for Xiromed, LLC, repackaged and distributed by Medical Purchasing Solutions, LLC.*

FDA Label Image

Glyco.jpg (Glyco)

Label for Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL) multiple dose vial. The label states it contains benzyl alcohol and is for intramuscular or intravenous administration, not for use in newborns. It is manufactured for Xiromed, LLC, Florham Park, NJ, and shows storage instructions along with a barcode.*

FDA Label Image

Glycopyrrolate-spl-structural-formula (Glycopyrrolate Spl Structural Formula)

Chemical structure of glycopyrrolate showing its molecular formula C19H28BrNO3 and molecular weight 398.33. The structure includes a quaternary ammonium group with a bromide counterion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.